About Fermentis Life Sciences Private Limited
Data last updated:
Fermentis Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290DL2017PTC326133. Its GSTIN is 06AADCF2469G1ZP (Haryana). The company holds 5 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹96.43 Lakh. It is led by directors including Bhuwan Chandra Fulara and Prakash Chandra Bhatt.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 187 Shyam Vihar Phase – 1 Najafgarh, Delhi, India – 110043.
As per the financials filed for FY 2025, the company reported a revenue of ₹120.47 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹2.28 Cr (net margin 1.9%) and EBITDA of ₹4.79 Cr (EBITDA margin 4%). Revenue has grown at a compounded annual rate (CAGR) of 90% over three years and 169% over five years.
The company has about 9 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Fermentis Life Sciences. As per MCA filings, the company has open charges of ₹42.22 Cr and satisfied charges of ₹2 Cr on record. Court records list 2 cases involving the company, including 2 filed against it.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website fermentislife.com.
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressE – 187 Shyam Vihar Phase – 1 Najafgarh, Delhi, India – 110043
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Fermentis Life Sciences Private Limited
The main business activity of Fermentis Life Sciences is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Fermentis Life Sciences Private Limited FY 2025 filings available
Fermentis Life Sciences Private Limited reported revenue of ₹120.47 Cr (up 215% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Fermentis Life Sciences Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 169% over five years, including 215% growth in the latest year. EBITDA rose 186% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Fermentis Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹4.79 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.28 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Fermentis Life Sciences Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Fermentis Life Sciences are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Preventive Healthcare Supplements). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Bio-Pharma Laboratories Private Limited | ₹137.45 Cr (FY 2024) | •••• | •••• | 64.0% | •••• | Bollaram, Telangana, India |
| Soma Nutrition Labs Private Limited | ₹136.81 Cr (FY 2024) | •••• | •••• | -42.0% | •••• | Purandar, Maharashtra, India |
| Ingex Lab Private Limited | ₹131.49 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Bangalore, Karnataka, India |
| Yakult Danone India Private Limited | ₹125.82 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Muscle House (I) Private Limited | ₹125.12 Cr (FY 2025) | •••• | •••• | 35.0% | •••• | New Delhi, Delhi, India |
| Fermentis Life Sciences Private Limited this company | ₹120.47 Cr (FY 2025) | •••• | •••• | 215.0% | •••• | Delhi, India |
| Hexagon Nutrition (Exports) Private Limited | ₹120.1 Cr (FY 2025) | •••• | •••• | 7.0% | •••• | Mumbai, Maharashtra, India |
| Amol Pharmaceuticals Private Limited | ₹119.9 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Jaipur, Rajasthan, India |
| Nutritionalab Private Limited | ₹118.97 Cr (FY 2025) | •••• | •••• | 65.0% | •••• | Mumbai, Maharashtra, India |
| British Life Sciences Private Limited | ₹117.8 Cr (FY 2024) | •••• | •••• | 34.0% | •••• | Bangalore, Karnataka, India |
| Trophic Wellness Private Limited | ₹111.06 Cr (FY 2025) | •••• | •••• | 8.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Fermentis Life Sciences by revenue in the Healthcare industry (Preventive Healthcare Supplements), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited is audited by SPMG & Co. for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SPMG & Co. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Fermentis Life Sciences Private Limited
Fermentis Life Sciences has 3 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Bhuwan Chandra Fulara | Director | 17 Nov 2017 | 8 Years 10 Months | Current |
| Prakash Chandra Bhatt Also directs: Musclemonk Nutrisports Private Limited, Nuroot Health Sciences Private Limited, Momzlab Private Limited and 1 more | Director | 17 Nov 2017 | 8 Years 10 Months | Current |
| Preeti Pandey | Director | 01 Sep 2025 | 1 Years 1 Months | Current |
Ownership and Shareholding of Fermentis Life Sciences Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Fermentis Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Jun 2026 | Hdfc Bank Limited | ₹1.59 Cr | Open |
| 13 Nov 2025 | Hdfc Bank Limited | ₹20 Cr | Open |
| 30 Aug 2022 | Hdfc Bank Limited | ₹10.08 Lakh | Open |
| 16 Mar 2022 | Hdfc Bank Limited | ₹13.54 Lakh | Open |
| 23 Sep 2021 | Hdfc Bank Limited | ₹20 Cr | Open |
Total charge records: 9 View all charges
Legal Cases of Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited has 2 court cases on record: 2 filed against it. All cases are disposed. Status as checked on 03 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 2 | 0 |
Cases on record (1 of 2)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ghaziabad, Uttar Pradesh | Criminal case | Filed against the company by State Government | Disposed |
Full case history
All 2 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME Payment Delays by Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 83 overdue payments to 9 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 9)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Pranil Polymers Limited | •••• | •••• | •••• |
| Jagdambha Industries | •••• | •••• | •••• |
| Vca Healthcare Private Limited | •••• | •••• | •••• |
| Flavaroma Flavours and Fragrances Private Limited | •••• | •••• | •••• |
| an individual supplier | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Associated Brands with Fermentis Life Sciences Private Limited
Fermentis Life Sciences operates one associated brand: Fermentis Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Manufactures nutraceutical products including tablets, capsules, and powders for health. | fermentislife.com |
Employees and EPFO Compliance at Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited has a workforce of 9 employees as of Sep 22, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Fermentis Life Sciences Private Limited
Fermentis Life Sciences Private Limited has 6 board changes on record since 2017: 3 appointments and 3 cessations. The latest: Preeti Pandey was appointed as Director on 01 Sep 2025.
9 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Fermentis Life Sciences Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Fermentis Life Sciences Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Fermentis Life Sciences Private Limited
Fermentis Life Sciences has 5 GST registrations: 1 active and 4 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AADCF2469G1ZP | Haryana | Active | 19 Jul 2018 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Fermentis Life Sciences Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Fermentis Life Sciences Private Limited
Fermentis Life Sciences is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 November 2017 (9+ years old) and is registered under CIN U24290DL2017PTC326133.
Fermentis Life Sciences reported revenue of ₹120.47 Cr for FY 2025 (up 215% YoY).
Fermentis Life Sciences has 3 current directors:
- Bhuwan Chandra Fulara - Director
- Prakash Chandra Bhatt - Director
- Preeti Pandey - Director
Fermentis Life Sciences reported a net profit of ₹2.28 Cr (net margin 1.9%) and EBITDA of ₹4.79 Cr (EBITDA margin 4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Fermentis Life Sciences is 90% over three years and 169% over five years. In the latest year (FY 2025) revenue rose 215%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Fermentis Life Sciences is 06AADCF2469G1ZP, registered in Haryana. The company has 5 GST registrations in all, of which 1 is active and 4 are cancelled or inactive.
The CIN (Corporate Identification Number) of Fermentis Life Sciences is U24290DL2017PTC326133. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Fermentis Life Sciences has 2 court cases on record: 2 filed against it.
Fermentis Life Sciences was incorporated on 17 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Fermentis Life Sciences by revenue are Bio-Pharma Laboratories Private Limited, Soma Nutrition Labs Private Limited, Ingex Lab Private Limited, Yakult Danone India Private Limited, Muscle House (I) Private Limited and 5 more, all in the Healthcare industry (Preventive Healthcare Supplements).
Preeti Pandey was appointed as Director on 01 Sep 2025. Shiv Pratap Singh ceased to be Director on 13 Oct 2020. Rajendra Kumar Bhatt ceased to be Director on 28 Dec 2019. Fermentis Life Sciences has 6 board changes on record in total.
Fermentis Life Sciences has 1 MSME Form 1 return on record for the period ending Mar 2024, listing 83 overdue payments to 9 micro and small suppliers. The latest return was filed on 20 May 2024.